Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 6: 37630, 2016 11 28.
Article in English | MEDLINE | ID: mdl-27892477

ABSTRACT

Protein aggregation is a hallmark of many neurodegenerative diseases, notably Alzheimer's and Parkinson's disease. Parkinson's disease is characterized by the presence of Lewy bodies, abnormal aggregates mainly composed of α-synuclein. Moreover, cases of familial Parkinson's disease have been linked to mutations in α-synuclein. In this study, we compared the behavior of wild-type (WT) α-synuclein and five of its pathological mutants (A30P, E46K, H50Q, G51D and A53T). To this end, single-molecule fluorescence detection was coupled to cell-free protein expression to measure precisely the oligomerization of proteins without purification, denaturation or labelling steps. In these conditions, we could detect the formation of oligomeric and pre-fibrillar species at very short time scale and low micromolar concentrations. The pathogenic mutants surprisingly segregated into two classes: one group forming large aggregates and fibrils while the other tending to form mostly oligomers. Strikingly, co-expression experiments reveal that members from the different groups do not generally interact with each other, both at the fibril and monomer levels. Together, this data paints a completely different picture of α-synuclein aggregation, with two possible pathways leading to the development of fibrils.


Subject(s)
Fluorescence , Mutant Proteins/chemistry , Protein Aggregates , Protein Aggregation, Pathological , Single Molecule Imaging/methods , alpha-Synuclein/chemistry , Models, Biological , Molecular Weight , Mutant Proteins/ultrastructure , Nanoparticles , Protein Biosynthesis , Protein Multimerization , Temperature , Ultracentrifugation , alpha-Synuclein/ultrastructure
2.
Nat Struct Mol Biol ; 22(12): 1008-15, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26571108

ABSTRACT

Polyglutamine (polyGln) expansions in nine human proteins result in neurological diseases and induce the proteins' tendency to form ß-rich amyloid fibrils and intracellular deposits. Less well known are at least nine other human diseases caused by polyalanine (polyAla)-expansion mutations in different proteins. The mechanisms of how polyAla aggregates under physiological conditions remain unclear and controversial. We show here that aggregation of polyAla is mechanistically dissimilar to that of polyGln and hence does not exhibit amyloid kinetics. PolyAla assembled spontaneously into α-helical clusters with diverse oligomeric states. Such clustering was pervasive in cells irrespective of visible aggregate formation, and it disrupted the normal physiological oligomeric state of two human proteins natively containing polyAla: ARX and SOX3. This self-assembly pattern indicates that polyAla expansions chronically disrupt protein behavior by imposing a deranged oligomeric status.


Subject(s)
Amyloid/metabolism , Peptides/chemistry , Peptides/metabolism , Protein Aggregation, Pathological , Protein Multimerization , Humans , Protein Structure, Secondary
SELECTION OF CITATIONS
SEARCH DETAIL
...